Home Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd
 

Keywords :   


Zacks Gives Neutral Rating to Teva Pharmaceutical Industries Ltd

2013-02-12 11:19:20| Biotech - Topix.net

The firm currently has a $41.00 target price on the stock. Zacks' analyst wrote, "Teva's fourth quarter earnings of $1.32 per American Depositary Share were a penny short of the Zacks Consensus Estimate and 17% below the year-ago earnings.

Tags: rating ltd industries neutral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 28
05.07Tropical Depression Aletta Graphics
05.07Hurricane Beryl Wind Speed Probabilities Number 28
05.07Hurricane Beryl Public Advisory Number 28
05.07Hurricane Beryl Forecast Advisory Number 28
05.07Tropical Depression Aletta Wind Speed Probabilities Number 5
05.07Tropical Depression Aletta Forecast Advisory Number 5
More »